Enlivex Therapeutics Ltd. (ENLV)
0.75
-0.04 (5.06%)
Upcoming Events
Latest Headlines
ENLIVEX TO PRESENT QUALITY LONGEVITY MODEL POWERED BY PREDICTION MARKETS TREASURY AT PROOF OF TALK 2026
June 2, 2026 8:00 AM - StreetInsider
Enlivex to present Allocetra knee osteoarthritis data at EULAR congress
June 1, 2026 8:00 AM - StreetInsider
Allocetra Shows Durable 6-Month Efficacy in Knee Osteoarthritis Phase IIa Trial; Oral Presentation at EULAR 2026
June 1, 2026 8:00 AM - StreetInsider
Form 6-K Enlivex Ltd. For: May 28
May 28, 2026 8:05 AM - SEC Filing
Enlivex reports $1.16 billion RAIN token holdings as of May 27
May 28, 2026 8:01 AM - StreetInsider
Enlivex reports $1.16 billion RAIN token holdings value
May 28, 2026 8:00 AM - StreetInsider
Enlivex Treasury Portfolio Update: RAIN Holdings Valued at Approximately $1.16 Billion; Rain Foundation Appoints Industry Leaders to Advisory Board
May 28, 2026 8:00 AM - StreetInsider
Form 6-K Enlivex Ltd. For: May 27
May 27, 2026 8:05 AM - SEC Filing
Enlivex Treasury Portfolio Update: Rain Protocol Jumps Into Top Three Global Prediction Markets In League Table Following $100M In Additional Liquidity
May 27, 2026 8:00 AM - Globe NewsWire
Form 6-K Enlivex Ltd. For: May 18
May 18, 2026 8:02 AM - SEC Filing
Enlivex doses first US patient in phase 2b knee osteoarthritis trial
May 18, 2026 8:01 AM - StreetInsider
Enlivex Announces Dosing Of First Patient In The United States As Part Of Its Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis
May 18, 2026 8:00 AM - Globe NewsWire
Form 6-K Enlivex Ltd. For: May 15
May 15, 2026 4:22 PM - SEC Filing
Enlivex receives Nasdaq minimum bid price deficiency notice
May 15, 2026 4:17 PM - StreetInsider
Enlivex Announces Receipt of Nasdaq Minimum Bid Price Notification
May 15, 2026 4:10 PM - Globe NewsWire
Form 424B3 Enlivex Ltd.
May 1, 2026 4:17 PM - SEC Filing
Form EFFECT Enlivex Ltd.
May 1, 2026 9:29 AM - SEC Filing
ENLV's RAIN token lists on HTX cryptocurrency exchange
April 30, 2026 8:33 AM - StreetInsider
Enlivex Treasury Portfolio Update: Listing of the RAIN Token on HTX, a Leading Cryptocurrency Exchange
April 30, 2026 8:30 AM - StreetInsider
Enlivex Treasury Update: Total RAIN Holdings Rise to 78,819,756,062 Tokens as of April 27, 2026, Representing an Aggregated Value of $567 Million
April 28, 2026 8:30 AM - Globe NewsWire
Enlivex to Present Phase IIa 3-month and 6-month Data of Allocetra at OARSI 2026 World Congress
April 23, 2026 8:30 AM - Globe NewsWire
Form F-3 Enlivex Ltd.
April 21, 2026 4:16 PM - SEC Filing
Form 6-K Enlivex Ltd. For: Apr 21
April 21, 2026 8:32 AM - SEC Filing
Enlivex receives Danish approval for knee osteoarthritis trial
April 21, 2026 8:31 AM - StreetInsider
Enlivex Announces Second Regulatory Approval for Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis
April 21, 2026 8:30 AM - StreetInsider
Form 6-K Enlivex Ltd. For: Apr 08
April 8, 2026 8:34 AM - SEC Filing
Ondo Finance tokenizes Enlivex shares for non-US investors
April 8, 2026 8:31 AM - StreetInsider
Ondo Global Markets Tokenizes Enlivex’s Ordinary Shares
April 8, 2026 8:30 AM - StreetInsider
Enlivex Therapeutics (ENLV) PT Raised to $20 at H.C. Wainwright
April 7, 2026 7:44 AM - StreetInsider
Form 6-K Enlivex Ltd. For: Mar 26
March 26, 2026 8:32 AM - SEC Filing
Enlivex reports Rain Foundation launches AI agent interface for prediction markets
March 26, 2026 8:31 AM - StreetInsider
Enlivex Rain Update: Rain Launches an OpenClaw and AI Agent Interface Allowing Anyone To Create A Prediction Market Via A Single Prompt
March 26, 2026 8:30 AM - StreetInsider
Form 20-F Enlivex Ltd. For: Dec 31
March 25, 2026 8:40 AM - SEC Filing
Form 6-K Enlivex Ltd. For: Mar 25
March 25, 2026 8:31 AM - SEC Filing
Enlivex Reports Full-Year 2025 Results: Profit (Net Income) of $1.23 Billion and Diluted Earnings Per Share (EPS) of $25.48
March 25, 2026 8:30 AM - StreetInsider
D. Boral Capital says Enlivex Therapeutics (ENLV) debt offering, RAIN token exposure reflects 'strategically negative' shift
March 24, 2026 9:28 AM - StreetInsider
Form 6-K Enlivex Ltd. For: Mar 24
March 24, 2026 8:35 AM - SEC Filing
Enlivex secures $21 million debt financing and approves $20 million buyback
March 24, 2026 8:30 AM - StreetInsider
Enlivex Announces $21 Million Debt Financing, Decentralized Prediction Markets RAIN Token-Related Updates and $20 Million Share Repurchase Program
March 24, 2026 8:30 AM - StreetInsider
Form 6-K Enlivex Ltd. For: Mar 23
March 23, 2026 8:02 AM - SEC Filing
Enlivex receives FDA clearance for Phase 2b knee osteoarthritis trial
March 23, 2026 8:00 AM - StreetInsider
Quality Longevity Company Enlivex Receives Investigational New Drug (IND) Clearance from the FDA for Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis
March 23, 2026 8:00 AM - StreetInsider
Form 424B3 Enlivex Ltd.
March 20, 2026 4:05 PM - SEC Filing
Off The Hook Yachts and Enlivex Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
March 20, 2026 9:00 AM - StreetInsider
Form 3 Enlivex Ltd. For: Mar 18 Filed by: Hershkovitz Oren
March 18, 2026 7:15 AM - SEC Filing
Form 3 Enlivex Ltd. For: Mar 18 Filed by: Shlosberger Shachar
March 18, 2026 7:14 AM - SEC Filing
Form 3 Enlivex Ltd. For: Mar 18 Filed by: Hart Gili
March 18, 2026 7:14 AM - SEC Filing
Form 3 Enlivex Ltd. For: Mar 18 Filed by: NOVIK SHAI A
March 18, 2026 7:10 AM - SEC Filing
Form 3 Enlivex Ltd. For: Mar 18 Filed by: Pomerantz Roger
March 18, 2026 7:06 AM - SEC Filing
Form 3 Enlivex Ltd. For: Mar 18 Filed by: Havron Avraham
March 18, 2026 7:04 AM - SEC Filing
Form 3 Enlivex Ltd. For: Mar 18 Filed by: Galamidi Einat
March 18, 2026 7:02 AM - SEC Filing
Form S-8 Enlivex Ltd.
March 13, 2026 4:18 PM - SEC Filing
Full Article List
